When should a 58-year-old woman undergo cervical cancer screening with Pap smear (and HPV testing)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cervical Cancer Screening for a 58-Year-Old Woman

A 58-year-old woman should continue cervical cancer screening every 5 years with HPV and Pap co-testing (preferred) or every 3 years with Pap test alone (acceptable) until age 65, assuming she has not had adequate prior negative screening. 1

Screening Recommendations for Women Aged 30-65 Years

For women in this age group, the guidelines are clear and consistent across major organizations:

  • Preferred approach: Co-testing (HPV + Pap) every 5 years 2, 1, 3
  • Acceptable alternative: Pap test alone every 3 years 1, 3
  • Also acceptable: Primary HPV testing alone every 5 years (where FDA-approved testing is available) 4, 3

The 2019 ACS guidelines 1 and 2018 USPSTF recommendations 3 both strongly support continuing screening through age 65 for average-risk women. At 58 years old, this patient has approximately 7 more years of recommended screening.

When to STOP Screening (Critical for This Age Group)

Screening should be discontinued after age 65 ONLY if the patient meets ALL of these criteria 2, 1:

  • ≥3 consecutive negative Pap tests OR ≥2 consecutive negative co-tests (HPV + Pap)
  • These negative tests must have occurred within the past 10 years
  • The most recent test must be within the last 5 years
  • No history of CIN2 or higher-grade lesions in the past 20-25 years

Common Pitfall to Avoid

Many women aged 58-65 are incorrectly told they can stop screening simply because they're approaching 65. This is wrong. The patient must have documented adequate prior screening history. If screening history is unknown, incomplete, or shows any gaps, screening must continue through age 65 and potentially beyond until adequate negative screening is established 2.

Special Considerations That Would Change This Recommendation

Continue screening BEYOND age 65 if the patient has:

  • History of CIN2 or more severe diagnosis (continue for at least 20 years after treatment, even past age 65) 2
  • HIV infection or immunosuppression (screen twice in first year, then annually) 2
  • History of in utero DES exposure 2
  • History of cervical cancer 2

Do NOT screen if:

  • Total hysterectomy with cervix removal for benign reasons (no history of CIN2+ or cervical cancer) 1, 3

Practical Algorithm for This 58-Year-Old Patient

  1. Review screening history: Has she had 3 consecutive negative Paps OR 2 consecutive negative co-tests in the past 10 years with the most recent in the last 5 years?

    • NO → Continue screening every 3-5 years until age 65
    • YES → She can stop at age 65 if no high-risk history
  2. Check for high-risk factors: HIV+, immunosuppressed, history of CIN2+, DES exposure, prior cervical cancer?

    • YES → Different screening protocol applies (more frequent, may extend beyond 65)
    • NO → Follow standard recommendations above
  3. Verify cervix status: Has she had a hysterectomy?

    • Total hysterectomy with cervix removed for benign reasons → No screening needed
    • Cervix intact OR subtotal hysterectomy → Continue screening per above

Updated 2020 ACS Guidance

The most recent 2020 ACS guideline 4 now prefers primary HPV testing every 5 years starting at age 25, with co-testing or cytology alone as acceptable alternatives where primary HPV testing isn't available. However, for a 58-year-old already in the screening system, continuing with co-testing every 5 years or Pap alone every 3 years remains appropriate until age 65.

Annual screening is NOT recommended at any age 2, 5 as it provides minimal additional benefit with substantially increased harms from false positives and unnecessary procedures.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.